Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

BACKGROUND: BRCA1/BRCA2 germ line (GL) mutation carriers with pancreatic adenocarcinoma (PDAC) may have distinct outcomes. We recently described an apparent more favourable prognosis of surgically resected BRCA-associated PDAC patients in a single-arm, uncontrolled, retrospective study. However, the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Cancer
Hoofdauteurs: Golan, Talia, Sella, Tal, O'Reilly, Eileen M, Katz, Matthew H G, Epelbaum, Ron, Kelsen, David P, Borgida, Ayelet, Maynard, Hannah, Kindler, Hedy, Friedmen, Eitan, Javle, Milind, Gallinger, Steven
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2017
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355924/
https://ncbi.nlm.nih.gov/pubmed/28183138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.19
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items